These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1776456)

  • 21. Arylsulphatase B (Maroteaux-Lamy factor): a part of the enzyme system responsible for sulphate release from mucopolysaccharide fragment.
    Gniot-Szulzycka J; Donnelly PV
    FEBS Lett; 1976 May; 65(1):63-8. PubMed ID: 819304
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombocytopenia associated with galsulfase treatment.
    Doğan M; Cesur Y; Peker E; Oner AF; Dogan SZ
    Hum Exp Toxicol; 2011 Jul; 30(7):768-71. PubMed ID: 20670992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syringomyelia in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): imaging findings following bone marrow transplantation.
    Hite SH; Krivit W; Haines SJ; Whitley CB
    Pediatr Radiol; 1997 Sep; 27(9):736-8. PubMed ID: 9285734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up to five years experience with 11 mucopolysaccharidosis type VI patients.
    Brands MM; Oussoren E; Ruijter GJ; Vollebregt AA; van den Hout HM; Joosten KF; Hop WC; Plug I; van der Ploeg AT
    Mol Genet Metab; 2013 May; 109(1):70-6. PubMed ID: 23523338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of residual arylsulfatase B activity in feline mucopolysaccharidosis VI by thiol-induced subunit association.
    Vine DT; McGovern MM; Schuchman EH; Haskins ME; Desnick RJ
    J Clin Invest; 1982 Feb; 69(2):294-302. PubMed ID: 6799547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mucopolysaccharidosis type VI: clinical aspects, diagnosis and treatment with enzyme replacement therapy].
    Politei J; Schenone A; Blanco M; Szlago M
    Arch Argent Pediatr; 2014 Jun; 112(3):258-62. PubMed ID: 24862809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.
    Fillat C; Simonaro CM; Yeyati PL; Abkowitz JL; Haskins ME; Schuchman EH
    J Clin Invest; 1996 Jul; 98(2):497-502. PubMed ID: 8755662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arylsulfatase B activity in cultured retinal pigment epithelium: regional studies in feline mucopolysaccharidosis VI.
    Stramm LE; Desnick RJ; Haskins ME; Aguirre GD
    Invest Ophthalmol Vis Sci; 1986 Jul; 27(7):1050-7. PubMed ID: 3087904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype.
    Jurecka A; Golda A; Opoka-Winiarska V; Piotrowska E; Tylki-Szymańska A
    Mol Genet Metab; 2011 Dec; 104(4):695-9. PubMed ID: 21917494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)].
    Sukegawa K; Tomatsu S; Kondo N; Orii T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):446-8. PubMed ID: 9645105
    [No Abstract]   [Full Text] [Related]  

  • 31. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT.
    McGovern MM; Ludman MD; Short MP; Steinfeld L; Kattan M; Raab EL; Krivit W; Desnick RJ
    Birth Defects Orig Artic Ser; 1986; 22(1):41-53. PubMed ID: 3083886
    [No Abstract]   [Full Text] [Related]  

  • 32. Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment.
    Harmatz P; Shediac R
    Front Biosci (Landmark Ed); 2017 Jan; 22(3):385-406. PubMed ID: 27814620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer.
    Peters C; Rommerskirch W; Modaressi S; von Figura K
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):499-504. PubMed ID: 1904721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A novel nonsense point mutation in the arylsulfatase B gene with a severe type Maroteaux-Lamy syndrome].
    Xu M
    Hokkaido Igaku Zasshi; 1996 May; 71(3):359-67. PubMed ID: 8752530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four novel mutant alleles of the arylsulfatase B gene in two patients with intermediate form of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
    Voskoboeva E; Isbrandt D; von Figura K; Krasnopolskaya X; Peters C
    Hum Genet; 1994 Mar; 93(3):259-64. PubMed ID: 8125475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a fluorometric microtiter plate-based enzyme assay for arylsulfatase B (MPS VI) using dried blood spots.
    Ullal AJ; Millington DS; Bali DS
    Mol Genet Metab Rep; 2014; 1():465-467. PubMed ID: 27896124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow transplantation in the feline model of arylsulfatase B deficiency.
    Wenger DA; Gasper PW; Thrall MA; Dial SM; LeCouteur RA; Hoover EA
    Birth Defects Orig Artic Ser; 1986; 22(1):177-86. PubMed ID: 3083883
    [No Abstract]   [Full Text] [Related]  

  • 38. An improved method for heterozygote identification in feline and human mucopolysaccharidosis VI, arylsulfatase-B deficiency.
    McGovern MM; Vine DT; Haskins ME; Desnick RJ
    Enzyme; 1981; 26(4):206-10. PubMed ID: 6113958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving arylsulfatase activity determination in dried blood spots: Screening and diagnostic approaches for Maroteaux-Lamy syndrome (MPS VI).
    Franco PG; Pérez MJ; Aranda C; Adamo A; Silvestroff L
    Clin Chim Acta; 2015 Jun; 446():86-92. PubMed ID: 25896963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathology of the feline model of mucopolysaccharidosis VI.
    Haskins ME; Aguirre GD; Jezyk PF; Patterson DF
    Am J Pathol; 1980 Dec; 101(3):657-74. PubMed ID: 6778219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.